These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31267498)

  • 21. CRISPR/Cas9 Editing of the Plasmodium falciparum Genome.
    Adjalley S; Lee MCS
    Methods Mol Biol; 2022; 2470():221-239. PubMed ID: 35881349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimalarial Benzoxaboroles Target Plasmodium falciparum Leucyl-tRNA Synthetase.
    Sonoiki E; Palencia A; Guo D; Ahyong V; Dong C; Li X; Hernandez VS; Zhang YK; Choi W; Gut J; Legac J; Cooper R; Alley MR; Freund YR; DeRisi J; Cusack S; Rosenthal PJ
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4886-95. PubMed ID: 27270277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistence of chloroquine-resistant haplotypes of Plasmodium falciparum in children with uncomplicated Malaria in Lagos, Nigeria, four years after change of chloroquine as first-line antimalarial medicine.
    Oladipo OO; Wellington OA; Sutherland CJ
    Diagn Pathol; 2015 Apr; 10():41. PubMed ID: 25928117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasmodium falciparum Thioredoxin Reductase (PfTrxR) and Its Role as a Target for New Antimalarial Discovery.
    McCarty SE; Schellenberger A; Goodwin DC; Fuanta NR; Tekwani BL; Calderón AI
    Molecules; 2015 Jun; 20(6):11459-73. PubMed ID: 26111176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention and treatment of artemisinin-resistant falciparum malaria: update for international travellers.
    Wkly Epidemiol Rec; 2010 May; 85(21):195-6. PubMed ID: 20514733
    [No Abstract]   [Full Text] [Related]  

  • 26. The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study.
    Imwong M; Suwannasin K; Kunasol C; Sutawong K; Mayxay M; Rekol H; Smithuis FM; Hlaing TM; Tun KM; van der Pluijm RW; Tripura R; Miotto O; Menard D; Dhorda M; Day NPJ; White NJ; Dondorp AM
    Lancet Infect Dis; 2017 May; 17(5):491-497. PubMed ID: 28161569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic surveillance for monitoring the impact of drug use on Plasmodium falciparum populations.
    Ndiaye YD; Hartl DL; McGregor D; Badiane A; Fall FB; Daniels RF; Wirth DF; Ndiaye D; Volkman SK
    Int J Parasitol Drugs Drug Resist; 2021 Dec; 17():12-22. PubMed ID: 34333350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. UK malaria treatment guidelines.
    Lalloo DG; Shingadia D; Pasvol G; Chiodini PL; Whitty CJ; Beeching NJ; Hill DR; Warrell DA; Bannister BA;
    J Infect; 2007 Feb; 54(2):111-21. PubMed ID: 17215045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The response of a case of multidrug-resistant, Plasmodium falciparum malaria to an unusual combination of antimalarial drugs.
    Singh RK
    Ann Trop Med Parasitol; 2002 Jun; 96(4):417-8. PubMed ID: 12171623
    [No Abstract]   [Full Text] [Related]  

  • 30. Preliminary LC-MS Based Screening for Inhibitors of Plasmodium falciparum Thioredoxin Reductase (PfTrxR) among a Set of Antimalarials from the Malaria Box.
    Tiwari NK; Reynolds PJ; Calderón AI
    Molecules; 2016 Mar; 21(4):424. PubMed ID: 27043496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity.
    Lucchi NW; Komino F; Okoth SA; Goldman I; Onyona P; Wiegand RE; Juma E; Shi YP; Barnwell JW; Udhayakumar V; Kariuki S
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7540-7. PubMed ID: 26392510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An analytical presentation of drug resistance in Plasmodium falciparum and guidelines to formulate a drug strategy.
    Pandya AP; Sharma RS; Sahu GC
    J Commun Dis; 1995 Mar; 27(1):44-54. PubMed ID: 7636152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasmodium falciparum: new molecular targets with potential for antimalarial drug development.
    Gardiner DL; Skinner-Adams TS; Brown CL; Andrews KT; Stack CM; McCarthy JS; Dalton JP; Trenholme KR
    Expert Rev Anti Infect Ther; 2009 Nov; 7(9):1087-98. PubMed ID: 19883329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double-drug development against antioxidant enzymes from Plasmodium falciparum.
    Biot C; Dessolin J; Grellier P; Davioud-Charvet E
    Redox Rep; 2003; 8(5):280-3. PubMed ID: 14962365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple-Strain Malaria Infection and Its Impacts on
    Orwa TO; Mbogo RW; Luboobi LS
    Comput Math Methods Med; 2019; 2019():9783986. PubMed ID: 31341510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia.
    Otienoburu SD; Maïga-Ascofaré O; Schramm B; Jullien V; Jones JJ; Zolia YM; Houzé P; Ashley EA; Kiechel JR; Guérin PJ; Le Bras J; Houzé S
    Malar J; 2016 Sep; 15(1):452. PubMed ID: 27596849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug-resistant Plasmodium falciparum malaria in the eastern Transvaal.
    Deacon HE; Freese JA; Sharp BL
    S Afr Med J; 1994 Jul; 84(7):394-5. PubMed ID: 7709301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid Generation of Marker-Free P. falciparum Fluorescent Reporter Lines Using Modified CRISPR/Cas9 Constructs and Selection Protocol.
    Mogollon CM; van Pul FJ; Imai T; Ramesar J; Chevalley-Maurel S; de Roo GM; Veld SA; Kroeze H; Franke-Fayard BM; Janse CJ; Khan SM
    PLoS One; 2016; 11(12):e0168362. PubMed ID: 27997583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prophylaxis of Plasmodium falciparum infection in a human challenge model with WR 238605, a new 8-aminoquinoline antimalarial.
    Brueckner RP; Coster T; Wesche DL; Shmuklarsky M; Schuster BG
    Antimicrob Agents Chemother; 1998 May; 42(5):1293-4. PubMed ID: 9593172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes.
    Lo E; Hemming-Schroeder E; Yewhalaw D; Nguyen J; Kebede E; Zemene E; Getachew S; Tushune K; Zhong D; Zhou G; Petros B; Yan G
    PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005806. PubMed ID: 28746333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.